Back | Next |
home / stock / iova / iova message board
Subject | By | Source | When |
---|---|---|---|
what do you make of this data? | jondoeuk | investorshub | 06/14/2023 11:00:51 PM |
Posters TIDAL-01: A selected TIL process that enriches for | jondoeuk | investorshub | 06/14/2023 10:07:53 PM |
(OT): Turnstone Bio, working on selected TIL (+/- | jondoeuk | investorshub | 06/14/2023 10:03:40 PM |
$IOVA MomentumIts gaining last up | jondoeuk | investorshub | 06/12/2023 6:34:19 AM |
MomentumIts gaining last up | jondoeuk | investorshub | 06/11/2023 6:20:04 AM |
Down today. I wonder if that is because | jondoeuk | investorshub | 06/05/2023 10:36:41 PM |
First trading day after BLA acceptance is kind | soupa1 | investorshub | 05/30/2023 11:22:54 PM |
Priority Review granted with PDUFA action date of | jondoeuk | investorshub | 05/26/2023 9:49:10 PM |
''Next-generation TIL therapies aim to overcome suppressive barriers | jondoeuk | investorshub | 05/26/2023 9:39:43 PM |
ASCO A phase 3 study (TILVANCE-301) to assess the | jondoeuk | investorshub | 05/26/2023 7:09:01 PM |
Welp.... | Porterhouse10 | investorshub | 02/08/2023 4:12:32 PM |
Feb 17 $7.50 calls .70x.90c. Hmmmm | Porterhouse10 | investorshub | 02/07/2023 4:52:50 PM |
Those will not get filled. I got | dinogreeves | investorshub | 02/07/2023 5:52:30 AM |
Sitting .65c Feb 17 $7.50 calls, may | Porterhouse10 | investorshub | 02/03/2023 7:40:30 PM |
Jesus, what's the float here? Insiders and Institutions | Porterhouse10 | investorshub | 02/03/2023 2:37:13 PM |
1.5 million shares were bought after hours today | dinogreeves | investorshub | 01/26/2023 7:48:13 AM |
IOVA is super cheap, should be 50-60 dollars | dinogreeves | investorshub | 01/25/2023 6:22:23 PM |
Data from a PhI pilot trial https://aacrjournals.org/clincancerres/article-abstr | jondoeuk | investorshub | 10/21/2022 11:25:32 PM |
The company has received positive feedback from the | jondoeuk | investorshub | 04/08/2022 7:04:20 PM |
AACR posters https://www.iovance.com/wp-content/uploads/Chesney IOV-LUN-TiP-post | jondoeuk | investorshub | 04/08/2022 7:02:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
SAN CARLOS, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its first quarter 2024 ...
2024-04-28 14:44:00 ET There's a lot of excitement around Iovance Biotherapeutics (NASDAQ: IOVA) as its shares are up over 40% year-to-date. Investors and analysts both see even more upside for this mid-cap biotech stock in the long run. Today, however, the company remains deepl...
SAN CARLOS, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or the "Company"), a biote...